Document is current
Any future updates will be listed below
-
Authors
Nonaka, Toshihiro https://orcid.org/0009-0006-0261-5959
Murata, Daiki https://orcid.org/0000-0003-0201-0205
Yoshizato, Hiromu https://orcid.org/0009-0004-7933-3744
Kashimoto, Shohei https://orcid.org/0009-0000-2941-0116
Nakamura, Anna https://orcid.org/0000-0003-3903-0306
Morimoto, Tadatsugu https://orcid.org/0000-0002-3359-9684
Nakayama, Koichi https://orcid.org/0000-0002-7324-8862
-
Funding
Funding for this research was provided by:
Japan Society for the Promotion of Science (22K09383)
Japan Society for the Promotion of Science (22K09383)
Japan Society for the Promotion of Science (22K09383)
Japan Society for the Promotion of Science (22K09383)
Japan Society for the Promotion of Science (22K09383)
- License Information
-
More Information
Article History
Received: 18 December 2024
Accepted: 11 February 2025
First Online: 20 February 2025
Declarations
:
: The animal studies were performed after receiving approval from the Institutional Animal Care and Use Committee of Saga University (Application No. A2022-048-0).
: Not applicable.
: K.N. is a cofounder and shareholder of Cyfuse Biomedical KK, Chief Technical Officer of Arktus Therapeutics, and an inventor/developer designated on the patent for the bio-3D printer. Patent title: Method for Production of Three-Dimensional Structure of Cells; patent number: JP4517125. Patent title: Cell structure production device; patent number: JP5896104. The other authors declare that they have no competing interests with respect to the publication of this article.
